Page 2 of 212

So considerably

BARDA Exercises $6M Choice For Aeolus’ Acute Radiation Syndrome Drug The Biomedical Advanced Study and Advancement Authority exercised $6 million in additional contract choices under its advanced analysis and advancement contract with Aeolus Pharmaceuticals for AEOL-10150, a broad-spectrum catalytic antioxidant made to neutralize reactive oxygen and nitrogen species specifically, as cure for the pulmonary syndrome of acute radiation syndrome and delayed ramifications of acute radiation exposure . Continue reading

Antibodies take evolutionary leaps to fight microbes With cold and flu season completely swing.

Antibodies take ‘evolutionary leaps’ to fight microbes With cold and flu season completely swing, the fact that viruses and bacteria evolve is apparent with every sneeze rapidly, sniffle, and cough. A new statement in the January 2009 problem of The FASEB Journal, explains for the very first time how humans keep up with microbes by rearranging the genes that produce antibodies to international invaders . Continue reading

Page 2 of 212